<DOC>
	<DOCNO>NCT00477295</DOCNO>
	<brief_summary>This two-arm , randomize , double-blind , non-inferiority study use flexible dosing regime allow optimal zonisamide carbamazepine therapy individual subject . Assessment eligibility take place Screening Visit . The subject randomize either carbamazepine zonisamide arm Randomization Visit ( T1 ) . T1 must occur soon possible ( least within 14 day ) Screening Visit order optimize subject care .</brief_summary>
	<brief_title>A Double-blind Study Compare Efficacy Safety Zonisamide Carbamazepine Monotherapy , Newly Diagnosed Partial Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>INCLUSION CRITERIA : Subjects eligible study meet follow inclusion criterion : 1 . Male female subject , 18 75 year age inclusive . 2 . Subjects untreated , newly diagnose epilepsy least two well document , unprovoked , clinically evaluate classify partial seizure ( without secondary generalization ) generalize tonicclonic seizure ( without clear focal origin ) within 12 month Screening Visit , least one seizure occur within three month Screening Visit ( &gt; one seizure within 24 hour period count one seizure ) . 3 . Subjects either previous use AED , treatment one AED maximum duration two week Randomization Visit ( T1 ) . 4 . Subjects document electroencephalogram ( EEG ) within 12 month Screening Visit , compatible localizationrelated epilepsy ( exclude primary generalize epilepsy ) . 5 . Subjects document computed axial tomography ( CAT ) scan magnetic resonance imaging ( MRI ) scan confirm absence progressive neurological lesion within 12 month Screening Visit . 6 . Female subject without childbearing potential ( two year postmenopausal , bilateral oophorectomy tubal ligation , complete hysterectomy ) eligible . Female subject childbearing potential must pregnant confirmed negative pregnancy test screen randomization , must lactate must use medically acceptable form contraception , duration study one month follow discontinuation study drug . Medically acceptable contraception define oral contraception pill least 50 microgram ethinylestradiol per intake , contraceptive injection implant , intrauterine device place least three month . 7 . Subjects able willing follow investigational study procedure , maintain seizure diary , report AEs . 8 . Subjects able willing give write informed consent . EXCLUSION CRITERIA : Subjects meet follow exclusion criterion eligible study : 1 . Subjects history clinical investigation , include EEG data , suggestive idiopathic generalise epilepsy define International League Against Epilepsy ( ILAE ) . 2 . Subjects history absence , myoclonic , clonic , tonic , atonic seizure . 3 . Subjects history status epilepticus , and/or nonepileptic seizure ( e.g. , metabolic , pseudoseizures ) . 4 . Subjects experience seizure relate drug , alcohol , acute medical illness , mental retardation , subject situationrelated seizure . 5 . Subjects progressive encephalopathy finding consistent progressive CNS disease lesion ( e.g . infection , demyelination , tumour ) . 6 . Subjects history significant currently uncontrolled disease interfere conduct study assessment safety efficacy study drug . 7 . Subjects previously treat carbamazepine zonisamide . 8 . Subjects receive investigational drug device three month prior Screening Visit . 9 . Subjects know hypersensitivity sulfonamide , dibenzazepine derivative , tricyclic antidepressant . 10 . Subjects history bone marrow depression , low platelet count blood dyscrasia . 11 . Subjects history acute intermittent porphyria . 12 . Subjects history renal disorder ( serum creatinine level &gt; 135 Ã¬mol / l ( 1.5 mg/dL Screening Visit ) , hepatic disorder clinically significant abnormal liver function test ; aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 2 time upper normal limit . 13 . Subjects body weight less 40 kg . 14 . Subjects history progressive malignancy within previous 5 year ( exclude history nonmetastasized adequately treat cutaneous squamous cell carcinoma ) . 15 . Subjects history psychiatric illness mood disorder require electroconvulsive drug therapy within previous 6 month consider uncontrolled ; history suicide attempt ; alcohol drug abuse ; chronic treatment benzodiazepine barbiturate . 16 . Subjects currently take carbonic anhydrase inhibitor . 17 . Subjects history pancreatitis , nephrolithiasis hypercalcuria , clinically significant laboratory electrocardiographic abnormality , uncontrolled hypertension . 18 . Subjects currently take monoamine oxidase inhibitor ( MAOIs ) exclude medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Epilepsy</keyword>
</DOC>